Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

2 Recent Healthcare IPOs Can Soar More than 30% - Tempus AI (NASDAQ: TEM), Waystar Holding (NASDAQ: WAY)


July 5, 2024 ( Newswire) According to EY's Global IPO Trends Q2 2024, 80 new IPOs raised $17.8 billion in capital in the US between January and June. Better economic and business prospects were the leading cause of the rise in IPOs.

Saqib Iqbal, a financial analyst at, thinks now is the right time to act on recent IPOs as the case for the Feds rate cut in September looks bright.

  • Due to better economic prospects, recent IPOs raised $17.8 billion in the US in the year's first half.
  • Despite a 34% drop, TEM's Google-backing and $7 billion valuation makes it a compelling investment.
  • WAY has shown strong performance, with potential for a 35% rise by year-end.

"The storyline for a September cut would continue to develop if the data continues to indicate a contracting US job market and declining inflation. This will indicate that investors should now search for the most recent public offerings. Two such healthcare IPOs are Tempus AI (NASDAQ: TEM) and Waystar Holding Corp. (NASDAQ: WAY)."


Tempus AI uses artificial intelligence to analyze medical test results, enabling doctors to treat patients more precisely. The firm's revenue increased by 183% between 2002 and 2023.

On its first trading day, the price of Tempus AI shares was $37, the upper end of its intended range of $35 to $37. Due to its early success, the firm was valued at up to $7 billion.

Currently, the stock is down by 34%, but Google's financial backing says a lot about TEM. Therefore, Saqib believes this popular recent IPO will serve aggressive investors well.

Waystar Holding Corp. (NASDAQ: WAY)

Waystar Holding Corp. is a healthcare-focused software firm that offers streamlined payment methods to healthcare professionals. For the first three months of 2024, Waystar earned the top spot in five categories for Healthcare Payment Software Platforms.

In Q1 2024, Waystar's sales were close to $225 million, while its net loss was about $16 million. The stock was priced at $20 on the first trading day and has since gained more than 3%. If the projected growth continues, WAY can rise to $27 by the end of this year.

More Info:

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy: - A Leading Global Investor Website for Biotech Industry Stocks - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on